satprof, confusion still reigns over these vaccines, so let me fill in some of the gaps.
The Oxford vaccine is a viral vector vaccine. The UK has massive experience in developing this type of vaccine. It is 70.4% effective at stopping people getting Covid-19. Its efficacy is dose related. Half a dose plus a full dose 2-3 weeks later increases its efficacy to 90%. A full dose plus another full dose 2-3 weeks later has an efficacy of 70.4%. The dosage regimes have not been finalised as work needs to be done on technical matters involving the vaccine, so it's not simply a case of giving a half dose first and then a full dose a fortnight later. There are some indications that two half doses might work better. It's not straightforward for now and time will tell. On the bright side, early indications are that the Oxford vaccine prevents transmission as well as providing immunity. It remains the only vaccine for now that can do this. This immunity should lead to herd immunity in time. The vaccine currently costs £2.23 per shot and can be stored at 2-8 degrees C.
The Pfizer BioNTECH vaccine costs £29.47 for two jabs. Its based on mRNA and in a nutshell, tricks the body into making antibodies. It has been shown to be 90% effective and requires two jabs, three to four weeks apart. The storage temperature does represent a problem but there are ways around it. Pfizer have developed transportation containers that maintain the required temperature for days between countries. The freezers required only need to be installed in centres throughout the UK from which they dispatch the vaccine to regional centres where it can sit quite happily at normal fridge temperatures for a few days before the vaccines viability is destroyed. There a hundreds of these specialised freezers in research facilities and universities throughout the UK and production has been ramped up.
I've had the Oxford jab and suffered no ill effects apart from some soreness at the injection site overnight.